Tuesday, 02 January 2024 12:17 GMT

Veterinary Bioburden Testing Services Market To Reach $1.49 Billion By 2030 As Infection Control Requirements Intensify


Date:

(MENAFN- GlobeNewsWire - Nasdaq) Boost ROI with AI analytics, automated testing, cloud data systems and real-time IoT monitoring to cut turnaround times, improve accuracy and streamline compliance.

Dublin, Oct. 27, 2026 (GLOBE NEWSWIRE) -- "Veterinary BioBurden Testing Services Market Report 2026" has been added to ResearchAndMarkets.com's offering.

The global veterinary bioburden testing services market is experiencing strong growth, supported by heightened infection-control requirements, expanding livestock production and rising awareness of microbial contamination risks in animal healthcare. The market is projected to increase from $0.99 billion in 2025 to $1.07 billion in 2026, representing a compound annual growth rate (CAGR) of 8.3%.

Historical market growth has been driven by the increasing incidence of infections acquired in veterinary hospitals, wider demand for sterilization validation and expanding quality-control requirements in veterinary pharmaceutical manufacturing. Greater awareness of hygiene standards across veterinary clinics, diagnostic laboratories, research facilities and animal production environments has also increased demand for reliable veterinary microbial testing services.

The veterinary bioburden testing services market is forecast to reach $1.49 billion by 2030, expanding at a CAGR of 8.5%. Growth during the forecast period is expected to be supported by stricter regulatory standards governing veterinary sterilization and infection prevention, increased use of automated laboratory platforms and growing demand for rapid diagnostics and real-time contamination monitoring. Cloud-based data management, robotics-driven testing workflows and artificial intelligence-powered microbial risk analysis are also expected to improve laboratory efficiency and testing accuracy.

Key veterinary bioburden testing market trends include AI-driven microbial contamination detection, predictive bioburden analytics and automated high-throughput microbiological testing. Laboratories are increasingly adopting cloud-based platforms to manage testing data, document sterilization compliance and improve collaboration across veterinary healthcare networks. Internet of Things-enabled environmental monitoring systems are also supporting continuous microbial surveillance, while blockchain-based traceability tools offer potential improvements in sample tracking and contamination audit records.

The growing incidence of zoonotic diseases is a major factor contributing to market expansion. Increased agricultural activity, wildlife encroachment and intensive livestock farming are creating more frequent interactions among people, domestic animals and wildlife, increasing the potential for pathogen transmission. These risks are strengthening demand for veterinary bioburden testing services that help laboratories assess microbial loads, monitor potential pathogen reservoirs and support preventive infection-control programs.

Public health data underscores the need for stronger microbial monitoring. In June 2025, the Centers for Disease Control and Prevention reported that U.S. cases of West Nile virus disease increased from 1,132 in 2022 to 2,628 in 2023. This represented an increase of 1,496 cases and highlighted the importance of coordinated animal, environmental and human health surveillance. As authorities and veterinary organizations strengthen zoonotic disease preparedness, demand for dependable microbial detection and contamination assessment is expected to rise.

Growth in livestock production is also accelerating demand for veterinary bioburden testing. Rising populations, higher incomes and increased consumption of animal protein are encouraging producers to expand herd and flock sizes and adopt more intensive farming methods. Higher animal density can elevate the risk of microbial contamination and pathogen transmission, making systematic testing essential for protecting animal health, maintaining production standards and supporting food safety compliance.

In July 2025, information published by GOV.UK showed that total livestock output in the United Kingdom reached $23.42 billion (£20.1 billion) in 2024. This marked an increase of $1.28 billion (£1.1 billion), or 5.6%, compared with 2023. Continued growth in livestock production is expected to generate further demand for environmental monitoring, microbial identification, sterility assessment and related veterinary laboratory services.

Technology development remains a central competitive focus within the veterinary bioburden testing services market. Providers are investing in AI-enabled microbial analysis platforms to improve detection accuracy, reduce turnaround times and strengthen contamination assessment in veterinary laboratories and animal healthcare settings. Automated image recognition and advanced data analytics can help testing facilities identify and quantify microbial loads more efficiently while supporting quality-control and hygiene compliance programs.

In May 2025, Japan-based biotechnology company Carbgem launched Zone of Inhibition for Veterinary Medicine, known as ZOI VET. The AI-integrated microbial detection solution uses automated image recognition and data analysis to enhance contamination testing. The platform is designed to help veterinary laboratories and research facilities improve quality control, reinforce infection-prevention practices and maintain compliance with applicable hygiene standards.

North America was the largest region in the veterinary bioburden testing services market in 2025, while Asia-Pacific is expected to record the fastest growth during the forecast period. The market covers Asia-Pacific, Southeast Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. Countries assessed include Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, the United Kingdom, the United States, Canada, Italy and Spain.

Markets Covered:
1) By Test Type: Aerobic Plate Count; Anaerobic Plate Count; Fungal Count; Spore Count; Other Test Types
2) By Animal Type: Companion Animals; Livestock Animals; Other Animal Types
3) By Application: Pre-Sterilization Validation; Environmental Monitoring; Surgical Site Surveillance; Water Quality Testing; Pharmaceutical Manufacturing Quality Control; Infection Outbreak Investigation
4) By End User: Veterinary Hospitals; Diagnostic Laboratories; Research Institutes; Other End Users

Subsegments:
1) By Aerobic Plate Count: Standard Plate Count; Total Viable Count; Heterotrophic Plate Count; Surface Plate Count; Pour Plate Count
2) By Anaerobic Plate Count: Clostridium Count; Bacteroides Count; Anaerobic Culture Count; Deep Agar Plate Count; Roll Tube Method Count
3) By Fungal Count: Yeast Count; Mold Count; Total Fungal Count; Environmental Fungal Count; Pathogenic Fungal Count
4) By Spore Count: Bacterial Spore Count; Bacillus Spore Count; Clostridium Spore Count; Heat Resistant Spore Count; Thermophilic Spore Count
5) By Other Test Types: Coliform Count; Enterobacteriaceae Count; Pseudomonas Count; Staphylococcus Count; Salmonella Count

Time Series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.

Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.

Key Attributes:

Report Attribute Details
No. of Pages 250
Forecast Period 2026 - 2030
Estimated Market Value (USD) in 2026 $1.07 Billion
Forecasted Market Value (USD) by 2030 $1.49 Billion
Compound Annual Growth Rate 8.5%
Regions Covered Global


Companies Featured
The companies featured in this Veterinary BioBurden Testing Services market report include:

  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Laboratory Corporation of America Holdings
  • Eurofins Scientific SE
  • SGS SA
  • Intertek Group plc
  • Charles River Laboratories International Inc.
  • WuXi Biologics (Cayman) Inc.
  • Element Materials Technology Group Limited
  • STERIS Laboratories Inc.
  • WuXi AppTec Co. Ltd.
  • Pace Analytical Services LLC
  • North American Science Associates Inc.
  • Medistri SA
  • Microbac Laboratories Inc.
  • Almac Group Limited
  • Boston Analytical Inc.
  • Creative Bioarray
  • Pacific BioLabs Inc.
  • Accuratus Lab Services Inc.

For more information about this report visit

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN27102026004107003653ID1111875455


GlobeNewsWire - Nasdaq

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.



More Story

Search